Cellus Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

Cellus General Information

Description

Operator of a biopharmaceutical company intended to develop antibody drugs for cancer treatments. The company is developing antibody therapeutics and low-molecular compound therapeutics that block the mechanism by which tumor-associated macrophages promote cancer cell metabolism, providing cancer patients with an advanced-generation anticancer drug and companion diagnostic method for their cancer treatment.

Contact Information

Website
www.cellusbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 7th Floor, 8th Floor, Oyang Building, 10 Yulgok-ro 14-gil
  • Jongno-gu
  • Seoul
  • South Korea
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 7th Floor, 8th Floor, Oyang Building, 10 Yulgok-ro 14-gil
  • Jongno-gu
  • Seoul
  • South Korea

Cellus Timeline

2021202220232024
Date FoundedFinancing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private Completed Pre-Clinical Trials
4. Accelerator/Incubator 01-Sep-2022 Completed Pre-Clinical Trials
3. Early Stage VC (Series A) 01-May-2022 Completed Pre-Clinical Trials
2. Early Stage VC 03-Aug-2021 $2.09M $3.09M Completed Pre-Clinical Trials
1. Seed Round 01-Aug-2020 $1000K $1000K Completed Pre-Clinical Trials
To view Cellus’s complete valuation and funding history, request access »

Cellus Executive Team (2)

Name Title Board Seat
Seonggeun Kim Co-Founder & Chief Executive Officer
Seonwook Cho Co-Founder & CSO
To view Cellus’s complete executive team members history, request access »

Cellus Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Tech Incubator Program for Startups Accelerator/Incubator
Envester Venture Capital Minority
Nvestor (Korea) Venture Capital Minority
Shinhan Capital Venture Capital Minority
Bluepoint Partners Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Cellus FAQs

  • When was Cellus founded?

    Cellus was founded in 2020.

  • Who is the founder of Cellus?

    Seonggeun Kim and Seonwook Cho are the founders of Cellus.

  • Who is the CEO of Cellus?

    Seonggeun Kim is the CEO of Cellus.

  • Where is Cellus headquartered?

    Cellus is headquartered in Seoul, South Korea.

  • What industry is Cellus in?

    Cellus’s primary industry is Drug Discovery.

  • Is Cellus a private or public company?

    Cellus is a Private company.

  • What is Cellus’s current revenue?

    The current revenue for Cellus is .

  • How much funding has Cellus raised over time?

    Cellus has raised $3.09M.

  • Who are Cellus’s investors?

    Tech Incubator Program for Startups, Envester, Nvestor (Korea), Shinhan Capital, and Bluepoint Partners are 5 of 7 investors who have invested in Cellus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »